CSIMarket
 


Opiant Pharmaceuticals Inc   (OPNT)
Other Ticker:  
 
 

OPNT's Net Income Growth by Quarter and Year

Opiant Pharmaceuticals Inc 's Net Income results by quarter and year




OPNT Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.75 -0.69 1.07
III Quarter September -9.92 3.42 0.72 10.68
II Quarter June -11.74 1.68 -0.22 1.58
I Quarter March -12.19 -2.84 -1.68 -1.74
FY   -33.85 3.01 -1.87 11.59



OPNT Net Income third quarter 2022 Y/Y Growth Comment
Opiant Pharmaceuticals Inc in the third quarter 2022 recorded net loss of $ -9.92 millions.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Net Income growth. While Opiant Pharmaceuticals Inc ' s Net Income no change of % ranks overall at the positon no. 304 in the third quarter 2022.




OPNT Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - 375 % -93.26 % -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Opiant Pharmaceuticals Inc 's third quarter 2022 Net Income $ -9.92 millions OPNT's Income Statement
Opiant Pharmaceuticals Inc 's third quarter 2021 Net Income $ 3.42 millions Quarterly OPNT's Income Statement
New: More OPNT's historic Net Income Growth >>


OPNT Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -78.07 % - -89.98 %
III Quarter September - 103.57 % - 575.95 %
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #20
Overall #304

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #20
Overall #304
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Opiant Pharmaceuticals Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OPNT's III. Quarter Q/Q Net Income Comment
Although Opiant Pharmaceuticals Inc in the III. Quarter 2022 showed net loss of $ -9.92 millions, some analyst said, that this point to slight up side in contrast to the -11.74 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Opiant Pharmaceuticals Inc achieved highest sequential Net Income growth. While Opiant Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OPNT's III. Quarter Q/Q Net Income Comment
Although Opiant Pharmaceuticals Inc in the III. Quarter 2022 admitted net loss of $ -9.92 millions, some analyst mentioned, that those numbers are recovery compare to the -11.74 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Opiant Pharmaceuticals Inc achieved highest sequential Net Income growth. While Opiant Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Opiant Pharmaceuticals Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ -33.09 $ -19.75 $ -6.33 $ 3.01 $ 1.57
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - 91.53 % -
Seq. Net Income Growth (TTM) Overall Ranking # 307 # 0 # 0 # 188 # 0




Cumulative Net Income growth Comment
Opiant Pharmaceuticals Inc realized trailing twelve months net loss of $ -33 millions, in the Sep 30 2022, compare to Net Income of $ 2 millions a year ago.

Opiant Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
-111 %
-515.55 %
-2206.37 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 19
S&P 500 # 307
Cumulative Net Income growth Comment
Opiant Pharmaceuticals Inc realized trailing twelve months net loss of $ -33 millions, in the Sep 30 2022, compare to Net Income of $ 2 millions a year ago.

Opiant Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
-111 %
-515.55 %
-2206.37 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 19
S&P 500 # 307




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
OPNT's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for OPNT's Competitors
Net Income Growth for Opiant Pharmaceuticals Inc 's Suppliers
Net Income Growth for OPNT's Customers

You may also want to know
OPNT's Annual Growth Rates OPNT's Profitability Ratios OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Roe OPNT's Valuation Ratios OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio
OPNT's Roa OPNT's Inventory Turnover Ratio OPNT's Growth Rates OPNT's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Pediatrix Medical Group Inc -0.19%$ -0.195 millions
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc-4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Semler Scientific Inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Meridian Bioscience Inc -14.30%$ -14.301 millions
Elite Pharmaceuticals Inc -15.68%$ -15.684 millions
Lemaitre Vascular Inc -16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Retractable Technologies inc -17.43%$ -17.428 millions
Molecular Templates inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions
Biomx Inc -32.41%$ -32.410 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com